DA-5018.: Topical analgesic.

被引:6
作者
Park, NS [1 ]
Seong, CM [1 ]
Jung, YS [1 ]
Kim, WB [1 ]
Kim, SH [1 ]
机构
[1] Korea Res Inst Chem Technol, Taejon 305600, South Korea
关键词
capsavanil; KR-25018;
D O I
10.1358/dof.2000.025.11.599437
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The 2-chloroethylation of ethyl homovanillate (I) with 1-bromo-2-chloroethane and K2CO3 in acetone gives ethyl 2-[4-(2-chloroethoxy)-3-methoxyphenyl]acetate (II), which is treated with sodium azide in toluene followed by hydrolysis with aqueous NaOH in MeOH, yielding 2-[4-(2-azidoethoxy)-3-methoxyphenyl]acetic acid (IV). The reaction of (IV) with SOCl2 and Et3N affords the acyl chloride (V). The reaction of 3-iodo-o-xylene (VI) and acrylonitrile under the Heck reaction conditions - (Pd(OAc)(2), tri-o-tolylphosphine and Et3N in MeCN - gives an isomeric mixture of 3-(3,4-dimethylphenyl)-2-propenenitrile (VII), which is hydrogenated with Pd/C followed by Raney Nickel to provide 3-(3,4-dimethylphenyl)propylamine (IX). The coupling reaction between the acyl chloride (V) and amine (IX) with Et3N in CH2Cl2 gives the amide (X). Finally, Pd/C catalyzed hydrogenation of this compound affords 2-[4-(2-aminoethoxy)-3-methoxyphenyl]-N-[3-(3,4-dimethylphenyl)propyl]acetamide (1-3). Scheme 1.
引用
收藏
页码:1131 / 1137
页数:7
相关论文
共 27 条
[1]  
BAE EJ, 1997, J KOR DIABETES ASS, V21, P69
[2]  
Baek GH, 1999, B KOREAN CHEM SOC, V20, P232
[3]   Homovanillic amide derivatives as capsaicin analogs and their analgesic activity [J].
Baek, GH ;
Jung, YS ;
Cho, SJ ;
Seong, CM ;
Park, NS .
ARCHIVES OF PHARMACAL RESEARCH, 1997, 20 (06) :659-661
[4]   Bioisosterism:: Interchange of 4-OH to 4-NH2 in vanillin or homovanillin ring of capsaicinoids [J].
Cho, SJ ;
Jung, YS ;
Seong, CM ;
Park, WK ;
Kong, JY ;
Park, NS .
ARCHIVES OF PHARMACAL RESEARCH, 1999, 22 (02) :184-188
[5]  
HOLZER P, 1991, PHARMACOL REV, V43, P143
[6]  
KANG KK, 1997, J APPL PHARM, V5, P133
[7]  
KANG KK, 1996, J APPL PHARM, V4, P391
[8]  
KANG KK, 1996, J APPL PHARM, V4, P224
[9]  
KANG KK, 1997, J APPL PHARM, V5, P12
[10]  
KANG KK, 1996, J APPL PHARM, V4, P232